The TAXINOMISIS Project: A multidisciplinary approach for the development of a new risk stratification model for patients with asymptomatic carotid artery stenosis

Asymptomatic carotid artery stenosis (ACAS) may cause future stroke and therefore patients with ACAS require best medical treatment. Patients at high risk for stroke may opt for additional revascularization (either surgery or stenting) but the future stroke risk should outweigh the risk for peri/post‐operative stroke/death. Current risk stratification for patients with ACAS is largely based on outdated randomized‐controlled trials that lack the integration of improved medical therapies and risk factor control. Furthermore, recent circulating and imaging biomarkers for stroke have never been included in a risk stratification model. The TAXINOMISIS Project aims to develop a new risk stratification model for cerebrovascular complications in patients with ACAS and this will be tested through a prospective observational multicentre clinical trial performed in six major European vascular surgery centres.

[1]  Kunrong Wu,et al.  Pharmacogenetics of statins treatment: Efficacy and safety , 2019, Journal of clinical pharmacy and therapeutics.

[2]  M. Silvestrini,et al.  Misconceptions regarding the adequacy of best medical intervention alone for asymptomatic carotid stenosis. , 2019, Journal of vascular surgery.

[3]  V. Riambau,et al.  Review of serum biomarkers in carotid atherosclerosis. , 2019, Journal of vascular surgery.

[4]  G. Bergström,et al.  Novel Multiomics Profiling of Human Carotid Atherosclerotic Plaques and Plasma Reveals Biliverdin Reductase B as a Marker of Intraplaque Hemorrhage , 2018, JACC. Basic to translational science.

[5]  M. Goddard,et al.  Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity , 2018, Cardiovascular research.

[6]  D. Tousoulis,et al.  Coronary versus carotid artery plaques. Similarities and differences regarding biomarkers morphology and prognosis , 2018, Current opinion in pharmacology.

[7]  F. Mach,et al.  Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis. , 2018, International journal of cardiology.

[8]  F. Mach,et al.  Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis , 2018, European journal of clinical investigation.

[9]  H S Markus,et al.  Editor's Choice - Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). , 2018, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[10]  P. Blankestijn,et al.  Impaired kidney function is associated with intraplaque hemorrhage in patients undergoing carotid endarterectomy. , 2017, Atherosclerosis.

[11]  Dimitrios I. Fotiadis,et al.  Prediction of Atherosclerotic Plaque Development in an In Vivo Coronary Arterial Segment Based on a Multilevel Modeling Approach , 2017, IEEE Transactions on Biomedical Engineering.

[12]  Dimitrios I Fotiadis,et al.  Natural History of Carotid Atherosclerosis in Relation to the Hemodynamic Environment , 2017, Angiology.

[13]  T. Lehtimäki,et al.  Differentially expressed genes and canonical pathway expression in human atherosclerotic plaques – Tampere Vascular Study , 2017, Scientific Reports.

[14]  Antonis Sakellarios,et al.  Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic coronary angiographic study , 2017, European heart journal cardiovascular Imaging.

[15]  Gerard Pasterkamp,et al.  Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease , 2017, Nature Reviews Cardiology.

[16]  V. Salomaa,et al.  Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[17]  M. Fauvart,et al.  Multiplex SNP genotyping in whole blood using an integrated microfluidic lab-on-a-chip. , 2016, Lab on a chip.

[18]  M. Brown,et al.  Ten-year risk of stroke in patients with previous cerebral infarction and the impact of carotid surgery in the Asymptomatic Carotid Surgery Trial , 2016, International journal of stroke : official journal of the International Stroke Society.

[19]  Kim Ekroos,et al.  Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol , 2016, European heart journal.

[20]  Dimitrios I. Fotiadis,et al.  Three-dimensional reconstruction of coronary arteries and plaque morphology using CT angiography – comparison and registration with IVUS , 2016, BMC Medical Imaging.

[21]  T Richards,et al.  Non-invasive Carotid Artery Imaging to Identify the Vulnerable Plaque: Current Status and Future Goals. , 2015, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[22]  Marije Bosch,et al.  Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis , 2015, Stroke.

[23]  V. Fuster,et al.  The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. , 2015, Journal of the American College of Cardiology.

[24]  Jasjit S. Suri,et al.  Plaque Echolucency and Stroke Risk in Asymptomatic Carotid Stenosis: A Systematic Review and Meta-Analysis , 2015, Stroke.

[25]  M. Bots,et al.  Time-Dependent Changes in Atherosclerotic Plaque Composition in Patients Undergoing Carotid Surgery , 2014, Circulation.

[26]  A. Nicolaides,et al.  Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. , 2014, Journal of vascular surgery.

[27]  L. Hirt.  Progression Rate and Ipsilateral Neurological Events in Asymptomatic Carotid Stenosis , 2014, Stroke.

[28]  G. Pasterkamp,et al.  Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease , 2014, Cardiovascular Diabetology.

[29]  Pina C. Sanelli,et al.  Carotid Plaque MRI and Stroke Risk: A Systematic Review and Meta-analysis , 2013, Stroke.

[30]  L. Kappelle,et al.  Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease. , 2013, International journal of cardiology.

[31]  J. Grotta,et al.  Clinical practice. Carotid stenosis. , 2013, The New England journal of medicine.

[32]  K. Huber,et al.  Homocysteine Improves Risk Stratification in Patients Undergoing Endarterectomy for Asymptomatic Internal Carotid Artery Stenosis , 2013, Stroke.

[33]  Arno W Hoes,et al.  Serum extracellular vesicle protein levels are associated with acute coronary syndrome , 2013, European heart journal. Acute cardiovascular care.

[34]  A. Nicolaides,et al.  The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke. , 2013, Journal of Vascular Surgery.

[35]  C. Combescure,et al.  Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy , 2013, Thrombosis and Haemostasis.

[36]  Dimitrios I. Fotiadis,et al.  Computer simulation of three-dimensional plaque formation and progression in the carotid artery , 2013, Medical & Biological Engineering & Computing.

[37]  Diana Delgado,et al.  Cerebrovascular Reserve and Stroke Risk in Patients With Carotid Stenosis or Occlusion: A Systematic Review and Meta-Analysis , 2012, Stroke.

[38]  Dimitrios I Fotiadis,et al.  Novel methodology for 3D reconstruction of carotid arteries and plaque characterization based upon magnetic resonance imaging carotid angiography data. , 2012, Magnetic resonance imaging.

[39]  M. Woodward,et al.  Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker , 2012, Heart.

[40]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[41]  A. Nicolaides,et al.  Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. , 2010, Journal of vascular surgery.

[42]  E. Antman,et al.  Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. , 2010, JAMA.

[43]  R. Peto,et al.  10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial , 2010, Lancet.

[44]  H. Jäger,et al.  New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS) , 2010, Lancet Neurology.

[45]  P. Doevendans,et al.  Local Atherosclerotic Plaques Are a Source of Prognostic Biomarkers for Adverse Cardiovascular Events , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[46]  D. Moher,et al.  A catalogue of reporting guidelines for health research , 2010, European journal of clinical investigation.

[47]  J. Pelisek,et al.  Evaluation of Serum Matrix Metalloproteinases as Biomarkers for Detection of Neurological Symptoms in Carotid Artery Disease , 2009, Vascular and endovascular surgery.

[48]  O. Steichen.  Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis , 2009 .

[49]  J. Stevens,et al.  Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. , 2009, Journal of vascular surgery.

[50]  Risto Telama,et al.  Cohort profile: the cardiovascular risk in Young Finns Study. , 2008, International journal of epidemiology.

[51]  G. Donnan,et al.  Does the 'high risk' patient with asymptomatic carotid stenosis really exist? , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[52]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[53]  F. Moll,et al.  Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy. , 2007, Journal of vascular surgery.

[54]  M. Rizzo,et al.  Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. , 2006, Stroke.

[55]  A. Hofman,et al.  Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke: The Rotterdam Study , 2005, Circulation.

[56]  G. Pasterkamp,et al.  Athero-express: Differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design , 2004, European Journal of Epidemiology.

[57]  Nancy R Cook,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.

[58]  Renu Virmani,et al.  Healed Plaque Ruptures and Sudden Coronary Death: Evidence That Subclinical Rupture Has a Role in Plaque Progression , 2001, Circulation.

[59]  Gerhard Schroth,et al.  Comparison of the ECST, CC, and NASCET grading methods and ultrasound for assessing carotid stenosis , 2000, Journal of Neurology.

[60]  M J Davies,et al.  Mechanisms of progression in native coronary artery disease: role of healed plaque disruption , 1999, Heart.

[61]  H. Winn,et al.  Endarterectomy for asymptomatic carotid artery stenosis. Resolving the controversy. , 1995, JAMA.

[62]  W S Moore,et al.  Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. , 1993, The New England journal of medicine.

[63]  A Guillard.  [Carotid stenosis]. , 1972, Acquisitions medicales recentes.